149 results
Page 4 of 8
S-3ASR
egeuv 7bifa
8 Apr 21
Automatic shelf registration
4:11pm
S-3ASR
EX-5.1
0ed5l94nogtkqt
8 Apr 21
Automatic shelf registration
4:11pm
8-K
EX-99.1
andsss 3r
2 Mar 21
Orchard Therapeutics Reports 2020 Financial Results and Reviews Recent Accomplishments
7:05am
8-K
EX-10.1
p6b3dvttn2gvmltcby
9 Feb 21
Orchard Therapeutics Announces $150 Million Strategic Financing
7:10am
8-K
EX-99.1
tbmv4zd
3 Nov 20
Orchard Therapeutics Reviews Recent Portfolio Progress and Reports Third Quarter 2020 Financial Results
7:03am
S-8
EX-5.1
ghhg2p8
6 Aug 20
Registration of securities for employees
4:07pm
S-8
EX-99.2
9kjrbovzc8322uu
6 Aug 20
Registration of securities for employees
4:07pm
8-K
EX-99.1
utyb58hpbmenpyvt63
6 Aug 20
Orchard Therapeutics Advances New Strategic Plan and Reports Second Quarter 2020 Financial Results
7:03am
8-K
EX-99.1
a2wihors
20 Jul 20
Orchard Therapeutics Announces Orphan Drug and Rare Pediatric Disease Designations for OTL-203 for the Treatment of MPS-I
7:03am
8-K
EX-3.1
ovieoj0
19 Jun 20
Amendments to Articles of Incorporation or Bylaws
4:09pm
10-Q
EX-10.1
u653c
7 May 20
Quarterly report
4:03pm
10-Q
gbodrj3
7 May 20
Quarterly report
4:03pm
8-K
EX-99.1
3p841tf43uvn5hr4
7 May 20
Orchard Therapeutics Unveils New Strategic Plan and Reports First Quarter 2020 Financial Results
7:03am
DEF 14A
oxzab7xm il0e1
29 Apr 20
Definitive proxy
4:02pm
PRE 14A
cje592ujjuwv153c
14 Apr 20
Preliminary proxy
4:46pm